Skip to main content
. 2010 Jul 7;2010(7):CD001972. doi: 10.1002/14651858.CD001972.pub4

Yap 1979.

Methods Randomised, parallel group study conducted in USA. Patient, carer, assessor blind. No clear explanation of withdrawals. Pharaceutical and government funding. No recruitment dates given.
Participants Adults with mixed cancer. 56 patients, 60 episodes enrolled. 52 episodes, 48 patients completed.
Interventions 2 groups. 10 mg versus 50 mg troche clotrimazole, for 14 days.
Outcomes Clinical and mycological eradication (culture). 
 Unclear when assessment made.
Notes As number of episodes 60 nearly same as number of patients so episodes used in analysis.
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Unclear risk Quote: "A randomised double blind trial....".
Quote: "....a randomised double blind technique was used to divide the patients into two groups....".
Allocation concealment? Unclear risk No information given.
Blinding of participants and carers? Low risk Quote: "A randomised double blind trial....".
Blinding of outcome assessors? Low risk Quote: "A randomised double blind trial....".
Incomplete outcome data addressed? Unclear risk Quote: "56 cancer patients with 60 episodes of oropharyngeal candidiasis were entered into he study between September 1976 and September 1977".
Quote: "Eight patients 8 episodes were considered inevaluable". Of the remaining 48 patients there were 52 episodes of infection.
Comment: We don't know which group these patients were in.
Free of selective reporting? Low risk Comment: Clinical and mycological eradication (culture).
Free of other biases? High risk Quote: "If there was no clinical improvement after 5 days or the patients condition necessitated the start of systemic antifungal therapy, administration of the troches was discontinued".
Possible bias due to episodes rather than patients and data not independent.
Comment: Pharmaceutical and government funding.